Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy.

The journal of allergy and clinical immunology. Global(2023)

引用 0|浏览11
暂无评分
摘要
Long-term immunomodulation without any new safety signals was reported with PTAH immunotherapy in the largest safety data set and longest treatment duration for oral immunotherapy published to date.
更多
查看译文
关键词
PTAH,oral immunotherapy,peanut allergy,peanut (Arachis hypogaea) allergen powder,pooled safety,immunologic outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要